Request Sample Inquiry
Naloxone Market

Naloxone Market

Naloxone Market Global Industry Assessment & Forecast

# Pages:

151

Base Year:

2021

Nov - 2021

Format:

Report Code:

VMR-2021-0530

Segments Covered
  • By Route of Administration Injectables, Nasal, Oral
  • By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: 320.2 Million
Revenue 2028Revenue 2028: 743.25 Million
Revenue CAGRRevenue CAGR (2022 - 2028): 11.1
Fastest Growing Region Fastest Growing Region (2022 - 2028) North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst

Key Insights

The global Naloxone market was valued at USD 320.2 Million in 2020 and is projected to reach USD 743.25 Million by 2028, growing at a CAGR of 11.1% from 2021 to 2028.

Years Parameters
Historical Data (Actual Data) 2016-2020
Base Year Data 2020
Current Year Date 2021
Projected year data 2021-2026
Annual Market Size (2028) 743.25 Million
Annual Market Size (2021)
CAGR (2021 - 2028) 11.1%

Definition And Overview

Naloxone is a medication used to block the effects of opioids. It is commonly used to counter decreased breathing in opioid overdose. Naloxone may also be combined with an opioid, to decrease the risk of opioid misuse.


The global Naloxone market was valued at USD 320.2 Million in 2020 and is projected to reach USD 743.25 Million by 2028, growing at a CAGR of 11.1% from 2021 to 2028.

The global Naloxone market is segmented into product, application, regions, and countries. The regional segmentation covers current and forecasts demand on the basis of North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. All the segments are analyzed on the basis of current and future trends. The report covers a complete evaluation of the market based on competition, drivers, restraints, opportunities, trends, and industry-authenticated data. The market is estimated from 2016 to 2020 and forecast from 2021 to 2028. 

Yearly Infographics 320.2 Million 743.25 Million

COVID-19 Impact Analysis

Outbreak of COVID-19 led various countries impose strict lockdown measures during the initial stages of the pandemic. Numerous companies from different verticals faced challenges due to remote work environments. As a result, companies from various sectors switched to online/virtual platforms to maintain a steady flow in their daily business activities. Impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.


The report provides a completely separate chapter for COVID-19 Impact Analysis. This chapter includes:

o   Impact Assessment of COVID-19 Pandemic

o   Pre & Post COVID-19 Market Size

o   Qualitative analysis on the short term & long term impact of COVID-19 on the market

o   The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.

Market Insights

The rising prevalence of the opioids overdose is boosting growth of naloxone market. Incidence of opioid drug abuse in the developed as well as developing economies are increasing which is also considered as a factor for driving the market.

The increasing awareness about availability of naloxone for the treatment of the opioid overdose is further expected to drive the growth of the market in near future.

As naloxone becomes more available, it raises ethical concerns. Some people worry that it will worsen the opioid crisis by enabling people to abuse these drugs which is expected to hamper the growth of the market.

Global Naloxone Market Report Scope

Parameter Details
Market Size Provided for Years 2016-2028
Base Year 2020
Historic Years 2016-2020
Forecast Years 2021-2028
Market Size Provided In Terms Of Revenue & Volume
Segments Covered Route of Administration, Distribution Channel
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Countries Covered The U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, South East Asia, Brazil, Argentina, GCC Countries, and South Africa, among others
Companies Covered Pfizer, West Ward Pharmaceuticals, Amneal Pharmaceuticals, Sandoz, ADAPT Pharma, Mylan, kaleo, Amphastar Pharmaceuticals.
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Market Segmentation

Route of Administration  Analysis: Preview

On the basis of Route of Administration, the market is segmented into Injectables, Nasal, Oral. Injectables  held the highest share in 2020 and is expected to grow at a significant rate over the forecast period. This is attributed to the rising demand for the Injectables in developing countries such as China and India. Digitalization in Asia Pacific region has led to a surge in the usage of technology in various business processes over the past few years. Rising adoption of online platforms across various sectors along with analytical solutions, IoT, AI, and Blockchain technology to gain a competitive advantage is also paving the way for the Naloxone market growth.

Distribution Channel Analysis: Preview

Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. Hospital Pharmacies  held the largest share and is projected to grow at a notable CAGR over the coming years. Rising demand for Naloxone  in various countries such as the U.S., Germany, China, India, and Japan, among others is likely to support the growth of the market. Numerous companies are focusing on investing heavily in this application to cater the end user requirements effectively.

Global Naloxone Market: Route of Administration Segment Analysis

    • Injectables
    • Nasal
    • Oral

Global Naloxone Market: Distribution Channel Segment Analysis

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Regional Analysis Preview

On the basis of region, the global Naloxone market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region held a leading share of the global Naloxone market in 2020. Some of the major countries contributing to the market growth are the U.S., U.K., Germany, France, China, India, Japan, and South Korea. U.S. is considered as the most lucrative country for market players. This is attributed to the presence of major companies operating in the region.

Market Size, 2021 (USD Billion)
North America
Europe
Asia Pacific
South America
Middle East Africa

Global Naloxone Market: Regional Analysis

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

The market comprises of numerous small, medium, and large sized players spread across various geographies. Some of the main competitors in the global Naloxone market are Pfizer, West Ward Pharmaceuticals, Amneal Pharmaceuticals, Sandoz, ADAPT Pharma, Mylan, kaleo, Amphastar Pharmaceuticals.. The report covers company market share analysis which gives a comprehensive overview of the main competitors in the market. In addition, the report also covers major strategies adopted by market players such as new product launch, acquisitions & mergers, partnerships, collaborations & joint ventures, research & development, and regional expansion. The study also covers the product portfolio of major companies operating in the market.

Key Highlights – Global Naloxone Market

  • Global Naloxone Market is projected to reach USD 743.25 Million by 2028
  • North America held the highest share of the Naloxone market
  • Injectables held the largest share of the product segment in the Naloxone market
  • Hospital Pharmacies held the major share of the application segment in the Naloxone market

FAQ
Frequently Asked Question
  • The global Naloxone valued at 320.2 Million in 2020 and is expected to reach 743.25 Million in 2028 growing at a CAGR of 11.1%.

  • The prominent players in the market are Pfizer, West Ward Pharmaceuticals, Amneal Pharmaceuticals, Sandoz, ADAPT Pharma, Mylan, kaleo, Amphastar Pharmaceuticals..

  • The market is project to grow at a CAGR of 11.1% between 2021 and 2028.

  • The driving factors of the Naloxone include

    • The rising prevalence of the opioids overdose is boosting growth of naloxone market. Incidence of opioid drug abuse in the developed as well as developing economies are increasing which is also considered as a factor for driving the market.
    • The increasing awareness about availability of naloxone for the treatment of the opioid overdose is further expected to drive the growth of the market in near future.

  • North America was the leading regional segment of the Naloxone in 2020.